Abercrombie & Fitch Co., through its subsidiaries, operates as an omnichannel retailer in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company offers an assortment of apparel, personal care products, and accessories for men, women, and kids under the Abercrombie & Fitch, abercrombie kids, Your Personal Best, Hollister, and Gilly Hicks brands. It sells products through its stores, various wholesale, franchise, and licensing arrangements, as well as e-commerce platforms. Abercrombie & Fitch Co. was founded in 1892 and is headquartered in New Albany, Ohio.

Abercrombie & Fitch Company

In a report released yesterday, from CICC maintained a Buy rating on Tianneng Power International, with a price target of HK$8.50. Tianneng Power I...

CICC Keeps Their Buy Rating on Tianneng Power International (TIANF)

Berenberg Bank analyst Richard Hatch maintained a Buy rating on Antofagasta yesterday and set a price target of p3,700.00. Hatch covers the Basic M...

Antofagasta (ANTO): New Buy Recommendation for This Basic Materials Giant

In a report released today, Cosmos Chiu from CIBC maintained a Buy rating on OceanaGold, with a price target of C$72.00. According to TipRanks, Chi...

CIBC Remains a Buy on OceanaGold (OCANF)

There’s a lot to be optimistic about in the Materials sector as 3 analysts just weighed in on Idaho Strategic Resources (IDR), Hudbay Minerals (HBM...

Analysts Offer Insights on Materials Companies: Idaho Strategic Resources (IDR), Hudbay Minerals (HBM) and OceanaGold (OtherOCANF)

The latest announcement is out from Tianneng Power International ( ($HK:0819) ). Tianneng Power International has disclosed the audited 2025 financ...

Tianneng Power Subsidiary Tianneng Battery Posts Modest 2025 Profit Growth

OceanaGold ( ($TSE:OGC) ) has shared an announcement. OceanaGold has filed its Annual Information Form and updated NI 43-101 technical reports for ...

OceanaGold Updates Technical Reports, Confirms Free Cash Flow Outlook

The latest update is out from Can-Fite BioPharma ( ($CANF) ). On March 26, 2026, Can-Fite BioPharma reported its 2025 results and recent clinical m...

Can-Fite BioPharma Posts 2025 Loss but Highlights Long-Term Cancer Survival and Clinical Progress

There’s a lot to be optimistic about in the Consumer Cyclical sector as 2 analysts just weighed in on Abercrombie Fitch (ANF) and Cooper-Standard H...

Analysts Offer Insights on Consumer Cyclical Companies: Abercrombie Fitch (ANF) and Cooper-Standard Holdings (CPS)

Smaller companies are sensitive to interest rates. 


GAP, ANF, CAVA: The Russell 2000 Small-Cap Index Enters Correction Territory

Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on XPeng, Inc. ADR (XPEV) and Nissan Motor Co ...

Analysts Offer Insights on Consumer Cyclical Companies: XPeng, Inc. ADR (XPEV) and Nissan Motor Co (OtherNSANF)

Can-Fite BioPharma ( ($CANF) ) has provided an update. On March 17, 2026, Can-Fite BioPharma announced that the Israeli Patent Office allowed its p...

Can-Fite Secures Israeli Patent to Bolster Namodenoson Anti-Obesity Franchise

The latest update is out from Pan American Energy ( ($TSE:PNRG) ). Pan American Energy has begun its first diamond drilling program at the Tharsis ...

Pan American Energy Starts First Drill Program at Tharsis Critical Metals Project

Shandong Molong Petroleum Machinery ( ($HK:0568) ) has issued an update. Shandong Molong Petroleum Machinery has called its second extraordinary ge...

Shandong Molong Seeks Shareholder Mandate to Issue Up to 20% More H Shares

In a report released yesterday, Ben Davis from RBC Capital maintained a Hold rating on Antofagasta, with a price target of p3,600.00. According to ...

Antofagasta (ANTO) Receives a Hold from RBC Capital

In a report released yesterday, Harrison Reynolds from RBC Capital maintained a Buy rating on OceanaGold, with a price target of C$78.00. According...

RBC Capital Remains a Buy on OceanaGold (OCANF)

The latest update is out from Antofagasta ( ($GB:ANTO) ). Antofagasta has announced changes to the composition of its board committees, effective 1...

Antofagasta Refreshes Board Committee Membership Ahead of April 2026

An announcement from Can-Fite BioPharma ( ($CANF) ) is now available. On March 10, 2026, Can-Fite BioPharma held a Special General Meeting of Share...

Current Quarter	$1.28	Next Quarter	$2.54
Current Year	$10.71	Next Year	$11.72
QoQ Growth	+98.4%	YoY Growth	+9.4%
3Y EPS CAGR	+36.2%	Target Price	$119.50
Consensus	Buy	Upside	+23.2%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ANF	$97.00	+5.15%	546.47K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ANF	$97.00	+5.1%	546.47K
3
4
5
6

ANF

ANF

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Abercrombie & Fitch Company Data in Excel

Get Abercrombie & Fitch Company Data in Excel